Optimizing Kidney Fibrosis Spheroid Model using Design of Experiment (DoE)

Discover how the 3D In Vitro Rat Kidney Spheroid Assay is advancing fibrosis research with improved predictivity. Optimized using Design of Experiment (DoE), this innovative model offers effective anti-fibrotic screening, providing hope for better treatments against progressive organ failure.

Optimizing Kidney Fibrosis Spheroid Model using Design of Experiment (DoE)

Fibrosis, the accumulation of scar tissue in response to a variety of physiological and environmental insults, can lead to progressive organ failure. Despite the usefulness of fibrosis biomarkers in in vitro models to assess novel anti-fibrotics, these models have historically been poor predictors of in vivo efficacy due to complicated disease provenance and pathophysiology. However, there is growing recognition that 3-dimensional (3D) cellular models may offer superior predictivity by better recapitulating the complexity of diseased tissue. In this poster, we present the development of a 3D in vitro rat kidney spheroid assay to improve translation to in vivo models.

Utilizing Design of Experiment (DoE) for Optimizing Fibrosis Assays: To address the challenge of optimizing fibrosis assays, the traditional One Factor at a Time (OFAT) optimization of assay parameters is unrealistic for protracted fibrosis assays. Instead, we utilized a Design of Experiment (DoE) approach to evaluate multiple non-linear parameters simultaneously in a Design Expert statistical model. A D-optimal Response Surface model was developed to determine the parameters essential for evolution of a fibrotic phenotype by NRK-49F spheroids. DoE enabled a rapid and comprehensive evaluation of the assay design space. Testing 200 conditions across 5 numeric and 3 categorical parameters, we optimized our model for screening small molecules and validated against known TGF-b1 signaling inhibitors. Assay quality and response window were improved over the corresponding 2D assay.

Conclusion: In conclusion, the development and optimization of a 3D in vitro rat kidney spheroid assay using the DoE approach has improved the predictivity and relevance of fibrosis models. This innovative assay presents a promising platform for screening potential anti-fibrotic compounds, accelerating fibrosis research and contributing to improved treatments for progressive organ failure caused by fibrosis.

Loading form…

Thank you! Your download will begin shortly.